top of page
![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Boston_H_color%5B33632%5D_edited.png)
NERLYNX Educational Web Series
Thu, Jun 04
|You are invited to attend a virtual program
Protecting Patients with NERLYNX the only HER2-directed small molecule approved by the FDA in both eBC and mBC.
Registration is Closed
See other events
Time & Location
Jun 04, 2020, 6:00 PM
You are invited to attend a virtual program
Guests
About The Event
You are invited to attend a virtual program
to learn more about NERLYNX:
NERLYNX Educational Web Series
Protecting Patients with NERLYNX the only HER2-directed small molecule approved by the FDA in both eBC and mBC
The topics below will be covered:
• Current unmet need in HER2+ Breast Cancer
• Review of clinical outcomes
• Tolerability management and support tools
bottom of page